Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnquest Regulatory News (ENQ)

Share Price Information for Enquest (ENQ)

Share Price is delayed by 15 minutes
Get Live Data
22.85    -0.10 (-0.44%)
Bid:
22.75
Ask:
22.90
Spread: 0.15 (0.659%)
Market Cap: £425.26m
ENQ Live PriceLast checked at - London Stock Exchange

Intraday Enquest Share Chart

Total Voting Rights

19 Sep 2024 07:00

RNS Number : 7733E
EnQuest PLC
19 September 2024
 

FOR IMMEDIATE RELEASE 19 September 2024

 

ENQUEST PLC ("EnQuest" or "the Company")

TRANSACTIONS IN OWN SHARES

EnQuest PLC (the "Company") announces that, on 18 September 2024, it purchased the following number of its ordinary shares of 5 pence each (the "Ordinary Shares") through Merrill Lynch International ("Merrill Lynch"). Such purchase was effected pursuant to the instructions issued by the Company in accordance with the share repurchase arrangements entered into with Merrill Lynch, as announced on 29 April 2024.

Aggregated information of Ordinary Shares purchased on 18 September 2024 according to each trading venue:

Venue

Weighted average price paid per share (GBp)

Aggregate number of shares purchased

Lowest price paid per share (GBp)

Highest price paid per share (GBp)

London Stock Exchange

11.75

168,168

11.58

11.86

Chi-X

11.84

11,756

11.54

11.92

BATS

-

0

-

-

Turquoise

-

0

-

-

Total (all venues)

11.75

179,924

11.54

11.92

 

Since 29 April 2024, the Company has purchased 32,407,775 Ordinary Shares at a cost (including dealing and associated costs) of £4,387,027.84. Of those shares, 25,000,000 Ordinary Shares have been retained in Treasury and will be issued in due course to the Company's Employee Benefit Trust and 7,407,775 Ordinary Shares have been purchased for cancellation.

Following the cancellation of the purchased shares, there will be 1,908,516,564 Ordinary Shares in issue and 25,000,000 Shares in Treasury. The total voting rights in the Company will accordingly be 1,883,516,564. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.

A full breakdown of the individual trades made by Merrill Lynch on behalf of the Company as part of the share repurchase programme is attached to this document.

Attachment: http://www.rns-pdf.londonstockexchange.com/rns/7733E_1-2024-9-18.pdf

 

LEI: 2138008LJU6WFQWOXJ73

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

Enquiries:

 

EnQuest plc +44 (0)20 7925 4900

Kate Christ, Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRLPMRTMTABBTI
Date   Source Headline
18th Feb 20219:00 amRNSHolding(s) in Company
9th Feb 202110:00 amRNSHolding(s) in Company
5th Feb 20212:49 pmRNSHolding(s) in Company
4th Feb 20215:52 pmRNSHolding(s) in Company
4th Feb 20217:00 amRNSOperations update
4th Feb 20217:00 amRNSAgreement to acquire UKNS asset
3rd Feb 20212:45 pmRNSHolding(s) in Company
3rd Feb 20218:30 amRNSDirectorate Change
29th Jan 20219:12 amRNSBond PIK Announcement
21st Jan 20217:00 amRNSAcquisition
11th Jan 20212:12 pmRNSDirector/PDMR Shareholding
10th Dec 20207:00 amRNSDirectorate Change
24th Nov 20207:00 amRNSOperations update
23rd Oct 20208:56 amRNSBoard Appointment
15th Oct 20209:19 amRNSMaturity date extension: High Yield & Retail Notes
17th Sep 202010:07 amRNSDirector/PDMR Shareholding
14th Sep 20209:22 amRNSDirector/PDMR Shareholding
3rd Sep 20207:00 amRNSEnQuest PLC Half Year Results 2020
20th Aug 202011:14 amRNSAdmission to Trading
31st Jul 20207:00 amRNSEnQuest signs sale and purchase agreement
30th Jul 202010:37 amRNSBond PIK Announcement
29th Jun 20202:11 pmRNSPayments to governments
9th Jun 202012:20 pmRNSDirector/PDMR Shareholding
21st May 20204:20 pmRNSAGM Statement
21st May 20207:00 amRNSOperations update
4th May 202010:22 amRNSDirector/PDMR Shareholding
1st May 20204:26 pmRNSHolding(s) in Company
27th Apr 202010:52 amRNSDirector/PDMR Shareholding
24th Apr 20209:23 amRNSDirector/PDMR Shareholding
23rd Apr 20204:06 pmRNSNotice of AGM and Report & Accounts
21st Apr 202010:31 amRNSDirector/PDMR Shareholding
20th Apr 20203:25 pmRNSDirector/PDMR Shareholding
20th Apr 20202:55 pmRNSHolding(s) in Company
9th Apr 20207:00 amRNSEnQuest 2019 Full Year Results
8th Apr 20208:00 amRNSNotification of full year results announcement
2nd Apr 20201:42 pmRNSDirector/PDMR Shareholding
25th Mar 20202:57 pmRNSFull year results update
19th Mar 20204:16 pmRNSDirectorate Change
19th Mar 20207:00 amRNSOperations update
20th Feb 20203:58 pmRNSAdmission to Trading
4th Feb 20207:00 amRNSOperations update
31st Jan 202011:59 amRNSBond PIK Announcement
6th Jan 202012:14 pmRNSTotal Voting Rights
9th Dec 201910:39 amRNSDirector/PDMR Shareholding
4th Dec 201912:48 pmRNSBlock listing Interim Review
4th Dec 20197:00 amRNSEnQuest awarded Block PM409 PSC offshore Malaysia
3rd Dec 20192:32 pmRNSTotal Voting Rights
2nd Dec 20199:22 amRNSDirector/PDMR Shareholding
27th Nov 20198:40 amRNSDirector/PDMR Shareholding
21st Nov 20197:00 amRNSOperations update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.